Procter & Gamble Health Limited (PGHL)
Healthcare | Drug Manufacturers - Specialty & Generic
₹5230.5
1.22% (₹63.2)
Market Overview
| Market Cap | 86823682048 |
| Volume | 3622 |
| 52W High | ₹5850.0 |
| 52W Low | ₹4636.55 |
Key Ratios
| P/E Ratio | 36.67438 |
| EPS | 142.62 |
| Beta | 0.46 |
| Dividend Yield | 3.1% |
Financial Performance
Revenue Growth
-0.001%
Profit Margin
0.20402001%
ROE
0.33405998%
ROA
0.21078%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: -0.0% revenue growth indicates weak business expansion.
Profitability: 20.4% profit margin shows excellent operational efficiency.
Returns: ROE of 33.4% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 36.7x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹8682.4Cr
- Beta: 0.46 (Market Volatility)
- 52-Week Range: ₹4636.6 - ₹5850.0
Last Updated: 2025-04-16 01:46:47